Introduction
============

Hepatitis C virus (HCV) is the major cause to HCC and liver failure worldwide, moreover, China is considered as a high endemic area of HCV infection ([@b1-mmr-17-06-7559]--[@b4-mmr-17-06-7559]). HCV which belongs to the *Flaviviridae* family has only a positive single-stranded RNA genome encoding a precursor polyprotein of about 3000 amino acid residues ([@b5-mmr-17-06-7559]). HCV core protein plays an important role in the regulation of cell growth and host expression of genes that were crucial for infectivity, for instance, cell apoptosis ([@b6-mmr-17-06-7559],[@b7-mmr-17-06-7559]). After the infection of host cells by HCV, they initiate the defense ability which named as cell apoptosis. However, HCV core protein has evolved to inhibit the ability of host-mediated cell apoptosis ([@b8-mmr-17-06-7559]). It has been revealed that, apart from forming virus, HCV core proteins can modulate gene transcription, cell proliferation, cell apoptosis, and progression to HCC. Generally, HCV core protein appears to exert multiple effects on cell apoptosis which rely on the apoptotic stimuli as well as the cell type and microenvironment ([@b9-mmr-17-06-7559]). Though there are numerous reports describing the functions of HCV core proteins in cellular apoptosis, the mechanisms and impacts of these proteins in Huh-7 cell apoptosis have not so far been studied or reported.

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), also named Apo2L, belongs to the TNF superfamily and induces cell apoptosis typically in a variety of transformed cells but not healthy cells ([@b10-mmr-17-06-7559]). Moreover, it is reported that TRAIL also induces cell apoptosis in virus-infected cells, for instance, cells that are infected by HCV ([@b11-mmr-17-06-7559]). Therefore, TRAIL may serve an immune surveillance factor by selectively killing virus-infected cells.

It is well known that the tumor promoter protein p53 plays a key role in cell apoptosis, while the functional inactivation of p53 is often a crucial stage during tumorigenesis ([@b12-mmr-17-06-7559]). Through sirt1, when p53 protein is deacetylated, its DNA binding activity is impaired, consequently leading to a reduction in p53-mediated cell apoptosis in response to DNA damage ([@b13-mmr-17-06-7559],[@b14-mmr-17-06-7559]). BH3 interacting-domain death agonist (Bid), whose promoter has p53-binding sites and whose expression is regulated by p53, takes part in numberous apoptotic processes ([@b15-mmr-17-06-7559],[@b16-mmr-17-06-7559]). Be cleaved by other proteases or caspase-8, activated Bid translocates to the mitochondrial outer membrane and leads to the activation of Bcl-2-associated X protein (Bax)/Bak ([@b17-mmr-17-06-7559]).

In the present study, we focus on HCV core proteins of 3 different strains to explore the possible mechanisms and hunt for a novel therapeutic target for HCV infection.

Materials and methods
=====================

### Plasmids

The plasmids of pcDNA3.1, pcDNA3.1-C191, pcDNA3.1-NT and pcDNA3.1-T were conserved by our lab in Laboratory of Infectious Disease, Affiliated Hospital of Xuzhou Medical University.

### Cell culture and DNA transfection

The human hepatoma cell line Huh-7 was purchased from ATCC. Huh-7 cells were cultured in Dulbecco Minimum Essential Medium (DMEM; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (both Gibco; Thermo Fisher Scientific, Inc.) in an incubator at the temperature of 37°C and 5% CO~2~.

Transfection was performed using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) as recommended by the manufacturer. The p53-specific siRNA was purchased from Santa Cruz Biotechnology, Inc., Dallas, TX, USA (sc-29435). The siRNA was transfected into cells that were cultured in 6-well plates by Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) at the concentration of 100 pmol/well, or transfected into cells in 24-well plates with HiPerFect transfection reagent (Qiagen, Inc., Valencia, CA, USA) at the concentration of 37.5 ng/well.

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Total cellular RNA was purified from cultured Huh-7 cells using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.), in accordance with the manufacturer\'s instructions. Reverse transcription was performed by random primer and Moloney murine leukemia virus reverse transcriptase (Promega Corp., Madison, WI, USA), and cDNA was used as a template for RT-PCR. RT-qPCR was carried out using SYBR master mix (Toyobo Life Science, Osaka, Japan) and ABI7300. PCR conditions were as followed: 95°C for 60 sec followed by 40 cycles of 95°C for 15 sec, 60°C for 15 sec, and 72°C for 45 sec. The mRNA levels of casein kinase (CK)1α, CK1β, CK1γ, CK1δ and GAPDH (internal control) in Huh-7 cells were measured using the following primers: CK1α (sense, 5′-AGTGGCAGTGAAGCTAGAATCT-3′ and antisense, 5′-CGCCCAATACCCATTAGGAAGTT-3′) CK1ε (sense, 5′-TCCAAAGCCGAACTCGTTGT-3′ and antisense, 5′GATGCCCAGATAAACGTCTCC-3′), CK1γ (sense, 5′-ATGGACCATCCTAGTAGGGAAAA-3′ and antisense, 5′-CACATCCTATCTTCTTGCCAACC-3′), CK1δ (sense, 5′-CAGGAGAAGAGGTTGCCATCA-3′ and antisense, 5′-CAAGCAGCAGGACGGTTTTG-3′).

### Electron microscope

The Huh-7 cells from each group were collected into different centrifuge tubes, washed with phosphate-buffered saline (PBS; pH 7.4), carefully transferred into 0.25% glutaraldehyde using a pipette. Then, they were incubated at 4°C overnight. Subsequently, samples were fixed with 3% glutaraldehyde and 1% osmiumtetroxide. The fixed samples were dehydrated with a gradient series of acetone and embedded in Epon-812 agar (Shell Chemicals, Deer Park, TX, USA). Finally, the embedded samples, which were constructed into ultrathin sections by automatic semi-thin rotary microtome (Leica, Wetzlar, Germany) and stained with uranyl acetate/lead citrate, were observed under a Hitachi H-600IV transmission electron microscope (Hitachi, Tokyo, Japan). Images were captured accordingly.

### FACS analysis

Apoptosis assays were performed as manufacturer\'s instructions (BD Biosciences, Franklin Lakes, NJ, USA). For each sample, 0.3×10^6^ cells were seeded per 35-mm well and analyzed at 18 h (for apoptosis) or 72 h (for survival) after treatment, respectively. Annexin V-FITC/PI staining for apoptosis assays were conducted according to the manufacturer\'s protocols.

### Induction of apoptosis by TRAIL

Huh-7 cells (60--70% confluent) were seeded into 6-well plates. Three days post transfection, the Huh-7 cells were treated with recombinant human TRAIL (Perprotech, London, UK) for 2 h. Subsequently, cells were harvested, washed with PBS and stained with Annexin V as recommended by the manufacturer. The proportion of apoptotic cells was determined with flow cytometry.

### Western blot analysis

At 24 h after the cells were harvested, the protein expression levels were measured by WB analysis. Equal amounts of protein samples were resolved by 10% sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE), and transferred onto a nitrocellulose membrane (Amersham; GE Healthcare, Chicago, IL, USA). The membranes were probed using a polyclonal antibody against CK1α (1:1,000 ab108296; Abcam, Cambridge, UK), CK1ε (1:1,000; sc-373912; Santa Cruz Biotechnology, Inc.), CK1γ (1:1,000; ab64829), CK1δ (1:1,000; ab85320; both Abcam), Bid (1:1,000; 8762), caspase-8 (1:1,000; 4927; both Cell Signaling Technology, Inc., Danvers, MA, USA) at 4°C overnight. Thereafter, membrane was washed with TBST for 3 times, and incubated with secondary antibody at room temperature for 1 h. After wash for 3 times, blots were developed with SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific, Inc.). GAPDH (1:8,000; G5262; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) was used as an internal control for the comparison of protein load.

### Statistical analysis

The results were analyzed using GraphPad Prism 6.0 software (GraphPad Software, Inc., La Jolla, CA, USA) and are expressed as the mean ± standard deviation of at least 3 independent experiments. Comparisons between groups were performed using Student\'s t-test and one-way analysis of variance with Dunnett\'s post hoc test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### HCV core proteins induced Huh-7 cell apoptosis

The ratios of Annexin V/PI-positive human Huh-7 cells in different groups were quantified by flow cytometry. Compared with Huh-7 cells that were transfected with pcDNA3.1, total number of Annexin V-positive Huh-7 cells was significantly increased after transfection with three different core proteins ([Fig. 1A](#f1-mmr-17-06-7559){ref-type="fig"}).

Thereafter, we measured mRNA and protein levels of BAX and B-cell lymphoma 2 (Bcl-2) in Huh-7 cells that were transfected with three different HCV core plasmids 48 h later. As shown in [Fig. 1B-D](#f1-mmr-17-06-7559){ref-type="fig"}, Bcl-2 was significantly downregulated while BAX was significantly upregulated at both mRNA level and protein level in Huh-7 cells in groups transfected with core proteins than in group transfected with pcDNA3.1.

These results exhibited that all the different HCV core proteins induced Huh-7 cell apoptosis.

### Different strains of HCV core proteins elevated expression of CK1α in Huh-7 cells specifically

To explore the function of different strains of HCV core proteins (T, NT, C191), we firstly examined the changes of CK1 isoforms (CK1α, CK1ε, CK1γ and CK1δ) in Huh-7 cells after transfection with HCV core proteins. There were no statistical significance for changes of CK1ε, CK1γ and CK1δmRNA levels, while mRNA level of CK1α in Huh-7 cells that transfected with HCV core protein was statistically increased compared with mock group ([Fig. 2A](#f2-mmr-17-06-7559){ref-type="fig"}). Protein expression of CK1 isoforms was in accordance with mRNA level changes ([Fig. 2B](#f2-mmr-17-06-7559){ref-type="fig"}).

In conclusion, CK1α played a pivotal role in responding to the transfection of HCV core proteins into Huh-7 cells. It was unknown whether there were down-stream molecules that could be regulated or affected by CK1α.

### Successful construction of stable CK1α knock-down Huh-7 cells

To investigate the function of CK1α in Huh-7 cells which were transfected with different strains of HCV core proteins, virus-mediated shRNA CK1α was adopted to infect Huh-7 cells. Compared to the MOCK group and control group, mRNA level of CK1α was statistically decreased in the CK1α known-down group ([Fig. 3A](#f3-mmr-17-06-7559){ref-type="fig"}). Protein level of CK1α was in accord with changes of mRNA ([Fig. 3B](#f3-mmr-17-06-7559){ref-type="fig"}). There were not obvious morphological changes of Huh-7 cells among MOCK group, NC group and CK1α knockdown group ([Fig. 3C](#f3-mmr-17-06-7559){ref-type="fig"}).

Taken together, we obtained the stable CK1α knock-down Huh-7 cells. We aimed to further identify the influence of CK1α knock-down on Huh-7 cell behaviors and the related molecules.

### Knockdown of CK1α increased HCV core protein-induced cell apoptosis

We transfected 3 different HCV core proteins into non-CK1α-sileneced and CK1α-sileneced Huh-7 cells. Compared with non-CK1α-silenced Huh-7 cells, CK1α-silenced Huh-7 cells were more sensitive to cell apoptosis. Cell apoptotic ratio in the non-CK1α-silenced Huh-7 cells was 14.8% (C191), 14.74% (NT) and 17.13% (T), while cell apoptosis in the CK1α-silenced group was 18.2% (C191), 24.81% (NT) and 31.11% (T), respectively ([Fig. 4A](#f4-mmr-17-06-7559){ref-type="fig"}).

The protein levels of Bid and caspase8 in CK1α-silenced Huh-7 cells were notably higher than in non-CK1α-silenced Huh-7 cells ([Fig. 4B](#f4-mmr-17-06-7559){ref-type="fig"}).

We could draw the conclusion that, knockdown of CK1α upregulated HCV core protein-induced cell apoptosis. Whereas, the corresponding molecular mechanism was still unknown.

### CK1α knockdown upregulated HCV core protein levels and TRAIL-induced cell apoptosis

Since Trail could induce virus-infected cell apoptosis, we further tested whether HCV core protein-transfected CK1α-sileneced Huh-7 cells were sensitive to TRAIL. Flow cytometry revealed that, in non-CK1α-silenced Huh-7 cells transfected with 3 different HCV core protein, the cell apoptosis ratio was 24.35% (C191), 26.6% (NT) and 31.65% (T), which was significantly lower than that in CK1α-silenced group was 24.9% (C191), 46.6% (NT) and 50.77% (T) ([Fig. 5A](#f5-mmr-17-06-7559){ref-type="fig"}).

To investigate the corresponding mechanism, western blot analysis was adopted and exhibited that protein level of Bid in CK1α-silenced Huh-7 cells was obviously higher than in non-CK1α-silenced Huh-7 cells which was tightly associated with HCV core proteins of different strains. p53 that translocated to nuclear was also increased ([Fig. 5B](#f5-mmr-17-06-7559){ref-type="fig"}), indicating that translocation of p53 to nuclear initiated the transcription of Bid.

CHIp-PCR amplification demonstrated that p53 bound to the promoter regions of human Bid gene in Huh-7 cells ([Fig. 5C](#f5-mmr-17-06-7559){ref-type="fig"}).

We further measured the amount of Bid promoter precipitated by p53 in CK1α-silenced Huh-7 cells with RT-qPCR, and found that it was significantly higher than in non-CK1α-silenced Huh-7 cells which was also correlated with HCV core proteins of different strains ([Fig. 5D](#f5-mmr-17-06-7559){ref-type="fig"}).

### Knockdown of p53 decreased HCV core protein and TRAIL-induced cell apoptosis

To verify the function of p53 in TRAIL-induced cell apoptosis in the CK1α-sileneced Huh-7 cells that were transfected with HCV core proteins, we further transfected p53 siRNA or control siRNA into CK1α-sileneced Huh-7 cells which were transfected with T core protein. Results were measured by electron microscope, indicating that knockdown of p53 decreased HCV core protein and TRAIL-induced cell apoptosis ([Fig. 6A](#f6-mmr-17-06-7559){ref-type="fig"}). The protein levels of Bid and caspase-8 in CK1α-silenced Huh-7 cells that transfected with p53 siRNA were significantly lower than in control group ([Fig. 6B](#f6-mmr-17-06-7559){ref-type="fig"}).

In sum, we demonstrates that HCV core proteins sensitize host cells to TRAIL-induced cell apoptosis by activating CK1α-P53-Bid dependent pathway.

Discussion
==========

As the major cause of HCC and liver failure, HCV seriously affected the health of people worldwide ([@b1-mmr-17-06-7559]--[@b4-mmr-17-06-7559]). Therefore, it is urgent to explore effective treatments for HCV infection. In the past several years, the role of HCV core proteins in cell apoptosis has been debated, whereas, the mechanisms and impacts of HCV core proteins in Huh-7 cell apoptosis have not been reported yet ([@b18-mmr-17-06-7559]). The research data showed that HCV core proteins function as both promoter and suppressor during the process of apoptosis. In the present study, we aimed to provide an improved understanding of the effects of HCV core proteins on Huh-7 cell apoptosis, and we studied 3 different HCV strains to explore the corresponding possible mechanisms for the first time.

As acknowledged, CK1 was an ubiquitously serine/threonine protein kinase, furthermore, human CK1 was reported to take part in the controlling of cell differentiation as well as cell proliferation ([@b19-mmr-17-06-7559],[@b20-mmr-17-06-7559]). In current study, we found that all of the 3 HCV core proteins of different strains significantly upregulated the ratio of apoptotic Huh-7 cells, and they affected CK1α in Huh-7 cells specifically, which were in consistent with previous studies.

As p53 acting as a direct transcriptional activator of the apoptosis related genes ([@b12-mmr-17-06-7559]). In current study, we also found that knockdown of CK1α increased different HCV core protein-induced cell apoptosis and enhanced p53 translocating to nucleus, which were in line with a former reported research which demonstrated that CK1α knockdown activated p53 in cultured cells thus inducing obvious cell death ([@b21-mmr-17-06-7559]).

Whereas, under physiological circumstances, CK1α exhibits a more complex function during the process of tumor development ([@b22-mmr-17-06-7559]). A recent mouse model with tissue-specific knockout of CK1α in the gut revealed that CK1α depletion triggered p53 activation, induced cellular senescence and inhibited cell invasion significantly ([@b23-mmr-17-06-7559]). CK1α depletion, nevertheless, likewise led to stabilization of oncoprotein β-catenin, augmented cell proliferation and activation of DNA damage signals. The *in vivo* results consequently agree with the role of CK1α in inhibiting p53 function via interacting with MDMX, but p53 activation after CK1α depletion may affect additional mechanisms, for instance, oncogenic stress and DNA damage signaling pathways.

Because there were p53-binding sites in the promoter region of Bid, consequently, the expression of Bid was modulated by p53, and Bid participated in apoptotic processes ([@b15-mmr-17-06-7559],[@b16-mmr-17-06-7559]). Be cleaved by caspase-8, activated Bid could lead to the activation of Bax/Bak ([@b17-mmr-17-06-7559]). We carried out experiments to test their expression changes, and results revealed that during the progression of transfecting HCV core proteins, the expression levels of both Bid and caspase-8 were obviously upregulated. By CHIp assay, we found that the amount of Bid promoter which was associated with HCV core proteins of different strains was much higher in CK1α-silenced Huh-7 cells than in non-CK1α-silenced Huh-7 cells. Different HCV core proteins of different strains showed different abilities to induce cell apoptosis.

As acknowledged, TRAIL induced cell apoptosis in various transformed cells and HCV infected cells ([@b10-mmr-17-06-7559],[@b11-mmr-17-06-7559]). Therefore, TRAIL might selectively kill virus-infected cells. If HCV core protein enhances TRAIL-induced cell apoptosis, HCV-infected cells should preferentially be eliminated. To address the aforementioned question, we studied the impact of TRAIL on CK1α-silenced Huh-7 cells that were transfected with 3 different HCV core proteins. The results showed that CK1α played a crucial role in the aforementioned progression.

Therefore, it can be concluded from our findings that 3 different HCV core proteins induced Huh-7 cell apoptosis via the CK1α-p53-Bid signaling pathway, with CK1α acting as a key factor.

Whereas, there was only one cell line used in the present study, we will use more than one cell line as a model for the *in vitro* studies to confirm results in our future work.
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![Apoptotic and anti-proliferation effects of HCV core proteins in Huh-7 cells. Huh-7 cells were transiently transfected with three core proteins, and Huh-7 cells that were transfected with pcDNA3.1 were used as the negative control. (A) The ratio of Annexin V-positive Huh-7 cells was measured by flow cytometry (n=3). HCV core proteins were transiently transfected into Huh-7 cells. Following 48 h, mRNA levels of (B) Bcl-2 and (C) Bax (n=5) were measured. (D) Correspondingly, following 48 h, the protein levels of BAX and Bcl-2 were evaluated (n=5). \*P\<0.05 and \*\*P\<0.01 vs. pcDNA3.1. HCV, hepatitis C virus; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein; T, core proteins derived from tumor tissues; NT, core proteins derived from non-tumor tissues; C191, core proteins from the HCV-J6 strain.](MMR-17-06-7559-g00){#f1-mmr-17-06-7559}

![Transfection of HCV core proteins markedly elevated the expression levels of CK1α in Huh-7 cells. The (A) mRNA and (B) protein level of CK1 isoforms following transfection of HCV core protein of different strains. \*P\<0.05 and \*\*P\<0.01 vs. mock. HCV, hepatitis C virus; CK1, casein kinase 1; T, core proteins derived from tumor tissues; NT, core proteins derived from non-tumor tissues; C191, core proteins from the HCV-J6 strain.](MMR-17-06-7559-g01){#f2-mmr-17-06-7559}

![Successful construction of stable CK1α knockdown Huh-7 cells. (A) mRNA and (B) protein levels of CK1α among mock, NC and CK1α knockdown Huh-7 cells. (C) Cellular morphology of Huh-7 cells in different groups (magnification, ×100). \*\*P\<0.01 vs. mock. HCV, hepatitis C virus; CK1, casein kinase 1; NC, negative control.](MMR-17-06-7559-g02){#f3-mmr-17-06-7559}

![Knockdown of CK1α increased HCV core protein-induced cell apoptosis. (A) Cell apoptosis was measured by flow cytometry combined with Annexin V-fluorescein isothiocyanate/propidium iodide staining in control and CK1α knockdown cells. (B) Western blot analysis for the expression status of Bid and caspase-8 in control and CK1α knockdown cells that transfected with different HCV core proteins. HCV, hepatitis C virus; CK1, casein kinase 1; Bid, BH3 interacting-domain death agonist; NC, negative control; T, core proteins derived from tumor tissues; NT, core proteins derived from non-tumor tissues; C191, core proteins from the HCV-J6 strain.](MMR-17-06-7559-g03){#f4-mmr-17-06-7559}

![Knockdown of CK1α increased different HCV core proteins and TRAIL-induced cell apoptosis. (A) Cell apoptosis was tested by flow cytometry in control cells and CK1α knockdown cells that were induced by TRAIL (A). (B) Western blot analysis for the expression of Bid, p53 and PCNA in control and CK1α knockdown cells. (C) CHIP-PCR amplification demonstrated binding of p53 to the promoter regions of human Bid in Huh-7 cells. PCR was performed in input, p21-positive controls and IgG negative controls. (D) The quantitative PCR method was carried out for detecting the CHIp. TRAIL, tumor necrosis factor-related apoptosis-inducing ligand; HCV, hepatitis C virus; CK1, casein kinase 1; CHIP-PCR, chromatin immunoprecipitation-polymerase chain reaction; Bid, BH3 interacting-domain death agonist; NC, negative control; T, core proteins derived from tumor tissues; NT, core proteins derived from non-tumor tissues; C191, core proteins from the HCV-J6 strain; PCNA, proliferating cell nuclear antigen.](MMR-17-06-7559-g04){#f5-mmr-17-06-7559}

![Knockdown of p53 increased HCV core protein and TRAIL-induced cell apoptosis. (A) Cell apoptosis in Huh-7 cells that were transfected with control siRNA or p53 siRNA was measured by electron microscopy. Scale bars, top row=2 µm; bottom row=500 µm. (B) Western blot analysis for the expression level of Bid in control and p53 knockdown cells that were transfected with different HCV core proteins. HCV, hepatitis C virus; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand; CK1, casein kinase 1; Bid, BH3 interacting-domain death agonist; NC, negative control; siRNA, small interfering RNA; RNAi, RNA interference.](MMR-17-06-7559-g05){#f6-mmr-17-06-7559}
